Genetically Programmable Fusion Cellular Vesicles for Cancer Immunotherapy
Qian‐Fang Meng(Shenzhen Bay Laboratory), Lang Rao(National Institutes of Health), Lujie Liu(Shenzhen Bay Laboratory), Yuanwei Pan(National University of Singapore), Jialin Lai(Shenzhen Bay Laboratory), Zhida Liu(Shanxi Academy of Building Research), Chunbo Dong(Shanxi Academy of Building Research), Xiaoyuan Chen(Agency for Science, Technology and Research), Yuyue Zhao(Guangdong Province Stomatological Hospital), Guang‐Tao Yu(Wuhan University)
Cited by 118
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.3k
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis
|Nature Communications|2020|373
Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles
|Advanced Materials|2020|278
Supramolecular Polymerization‐Induced Nanoassemblies for Self‐Augmented Cascade Chemotherapy and Chemodynamic Therapy of Tumor
|Angewandte Chemie International Edition|2021|252